A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas

Study Purpose

The main aim of the study is to assess the quality of life of people with Crohn's disease after treatment for complex perianal fistulas in a standard clinic setting. Study doctors will review the participants' medical records in the last 3 years. Participants will also be asked to visit the clinic once to complete 1 questionnaire on their quality of life.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.

Searching Both is inclusive of interventional and observational studies.

Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

1. Diagnosed with CD. 2. Presence of CPF(s), defined as >=1 of the following criteria:
  • - High intersphincteric, high transsphincteric, extrasphincteric, or suprasphincteric location; - >=2 external openings; - Associated collections.
3. Attending routine gastroenterology appointments at the participating hospitals.

Exclusion Criteria:

1. Diagnosed with ulcerative colitis or indeterminate inflammatory bowel disease (IBD). 2. With non-complex fistulas or with fistulas types other than perianal (example, rectovaginal).

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.


Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Study Director
Principal Investigator Affiliation Takeda
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Overall Status Recruiting
Countries Portugal

The disease, disorder, syndrome, illness, or injury that is being studied.

Crohn Disease, Rectal Fistula
Study Website: View Trial Website
Additional Details

This is a national, observational, cross-sectional study. The study will assess the general QoL among CD participants with CPFs in the Portuguese routine clinical practice. This study will enroll approximately 80 participants. All participants will be enrolled in one observational cohort. The data will be collected retrospectively, from the medical records, on healthcare resource utilization and on the pharmacological and surgical treatments used for the management of CPFs in the three years prior to the inclusion visit. This multi-center trial will be conducted in Portugal. The overall duration of this study is approximately 8 months.

Arms & Interventions


: All Participants

Participants diagnosed with CD and CPF in the Portuguese routine clinical practice will be assessed. Retrospective data on healthcare resource utilization related with CPF management in the previous three years will be obtained from the medical records.


Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Coimbra, Portugal


Not yet recruiting


Centro Hospitalar e Universitario de Coimbra (CHUC)

Coimbra, , 3000-075

Site Contact

Site Contact


+351 966329152

Lisboa, Portugal


Not yet recruiting


Centro Hospitalar Universitario de Lisboa Central (CHULC)

Lisboa, , 1169-050

Site Contact

Site Contact


+351 966329715

Lisboa, Portugal




Centro Hospitalar Universitario Lisboa Norte - Hospital de Santa Maria (CHULN-HSM)

Lisboa, , 1649-028

Site Contact

Site Contact


+351 968644836

Porto, Portugal


Not yet recruiting


Centro Hospitalar Universitario de Sao Joao (CHUSJ)

Porto, , 4200-319

Site Contact

Site Contact


+351 962302089

Centro Hospitalar Tondela-Viseu (CHTV), Viseu, Portugal


Not yet recruiting


Centro Hospitalar Tondela-Viseu (CHTV)

Viseu, , 3504-509

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation. For a full description of terms please refer to our Terms, Conditions & Privacy.